Literature DB >> 21605163

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.

David E Blask1, Steven M Hill, Robert T Dauchy, Shulin Xiang, Lin Yuan, Tamika Duplessis, Lulu Mao, Erin Dauchy, Leonard A Sauer.   

Abstract

This review article discusses recent work on the melatonin-mediated circadian regulation and integration of molecular, dietary, and metabolic signaling mechanisms involved in human breast cancer growth and the consequences of circadian disruption by exposure to light at night (LAN). The antiproliferative effects of the circadian melatonin signal are mediated through a major mechanism involving the activation of MT(1) melatonin receptors expressed in human breast cancer cell lines and xenografts. In estrogen receptor (ERα+) human breast cancer cells, melatonin suppresses both ERα mRNA expression and estrogen-induced transcriptional activity of the ERα via MT(1) -induced activation of G(αi2) signaling and reduction of 3',5'-cyclic adenosine monophosphate (cAMP) levels. Melatonin also regulates the transactivation of additional members of the steroid hormone/nuclear receptor super-family, enzymes involved in estrogen metabolism, expression/activation of telomerase, and the expression of core clock and clock-related genes. The anti-invasive/anti-metastatic actions of melatonin involve the blockade of p38 phosphorylation and the expression of matrix metalloproteinases. Melatonin also inhibits the growth of human breast cancer xenografts via another critical pathway involving MT(1) -mediated suppression of cAMP leading to blockade of linoleic acid uptake and its metabolism to the mitogenic signaling molecule 13-hydroxyoctadecadienoic acid (13-HODE). Down-regulation of 13-HODE reduces the activation of growth factor pathways supporting cell proliferation and survival. Experimental evidence in rats and humans indicating that LAN-induced circadian disruption of the nocturnal melatonin signal activates human breast cancer growth, metabolism, and signaling provides the strongest mechanistic support, thus far, for population and ecological studies demonstrating elevated breast cancer risk in night shift workers and other individuals increasingly exposed to LAN.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605163      PMCID: PMC3162043          DOI: 10.1111/j.1600-079X.2011.00888.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  69 in total

Review 1.  A sense of time: how molecular clocks organize metabolism.

Authors:  Akira Kohsaka; Joseph Bass
Journal:  Trends Endocrinol Metab       Date:  2006-11-30       Impact factor: 12.015

2.  Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins.

Authors:  Todd L Kiefer; Ling Lai; Lin Yuan; Chunmin Dong; Matthew E Burow; Steven M Hill
Journal:  J Pineal Res       Date:  2005-05       Impact factor: 13.007

Review 3.  Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.

Authors:  Paula A Witt-Enderby; Nicholas M Radio; John S Doctor; Vicki L Davis
Journal:  J Pineal Res       Date:  2006-11       Impact factor: 13.007

4.  Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway.

Authors:  R Teclemariam-Mesbah; G J Ter Horst; F Postema; J Wortel; R M Buijs
Journal:  J Comp Neurol       Date:  1999-04-05       Impact factor: 3.215

5.  Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.

Authors:  Rainer Girgert; Christian Bartsch; Steven M Hill; Rolf Kreienberg; Volker Hanf
Journal:  Neuro Endocrinol Lett       Date:  2003-12       Impact factor: 0.765

6.  Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro.

Authors:  Mercedes M Leon-Blanco; Juan M Guerrero; Russel J Reiter; Juan R Calvo; David Pozo
Journal:  J Pineal Res       Date:  2003-10       Impact factor: 13.007

7.  p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.

Authors:  Mi-Sung Kim; Eun-Jung Lee; Hyeong-Reh Choi Kim; Aree Moon
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells.

Authors:  Jun Dai; Edward W Inscho; Lin Yuan; Steven M Hill
Journal:  J Pineal Res       Date:  2002-03       Impact factor: 13.007

9.  Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin.

Authors:  Beatriz del Río; Juana M García Pedrero; Carlos Martínez-Campa; Pedro Zuazua; Pedro S Lazo; Sofía Ramos
Journal:  J Biol Chem       Date:  2004-06-30       Impact factor: 5.157

10.  Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.

Authors:  W Yasui; H Tahara; E Tahara; J Fujimoto; J Nakayama; F Ishikawa; T Ide; E Tahara
Journal:  Jpn J Cancer Res       Date:  1998-11
View more
  53 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

3.  Effects of light at night on laboratory animals and research outcomes.

Authors:  Kathryn M Emmer; Kathryn L G Russart; William H Walker; Randy J Nelson; A Courtney DeVries
Journal:  Behav Neurosci       Date:  2018-06-28       Impact factor: 1.912

4.  Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.

Authors:  Robert T Dauchy; Shulin Xiang; Lulu Mao; Samantha Brimer; Melissa A Wren; Lin Yuan; Muralidharan Anbalagan; Adam Hauch; Tripp Frasch; Brian G Rowan; David E Blask; Steven M Hill
Journal:  Cancer Res       Date:  2014-08-01       Impact factor: 12.701

5.  Shedding light on the role of circadian disruption in breast cancer etiology.

Authors:  Pagona Lagiou
Journal:  Eur J Epidemiol       Date:  2016-08-22       Impact factor: 8.082

Review 6.  Artificial light at night: melatonin as a mediator between the environment and epigenome.

Authors:  Abraham Haim; Abed E Zubidat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-05-05       Impact factor: 6.237

Review 7.  Breast cancer and circadian disruption from electric lighting in the modern world.

Authors:  Richard G Stevens; George C Brainard; David E Blask; Steven W Lockley; Mario E Motta
Journal:  CA Cancer J Clin       Date:  2013-12-24       Impact factor: 508.702

8.  Altered tryptophan metabolism in human meningioma.

Authors:  Noble Kumar Talari; Manas Panigrahi; Sailaja Madigubba; Sundaram Challa; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2016-07-29       Impact factor: 4.130

Review 9.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

Review 10.  Health consequences of electric lighting practices in the modern world: A report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption.

Authors:  Ruth M Lunn; David E Blask; Andrew N Coogan; Mariana G Figueiro; Michael R Gorman; Janet E Hall; Johnni Hansen; Randy J Nelson; Satchidananda Panda; Michael H Smolensky; Richard G Stevens; Fred W Turek; Roel Vermeulen; Tania Carreón; Claire C Caruso; Christina C Lawson; Kristina A Thayer; Michael J Twery; Andrew D Ewens; Sanford C Garner; Pamela J Schwingl; Windy A Boyd
Journal:  Sci Total Environ       Date:  2017-07-27       Impact factor: 7.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.